Volume 66, Issue 6, Pages (December 2004)

Slides:



Advertisements
Similar presentations
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Advertisements

Acid-base profile in patients on PD
Home care assistance and the utilization of peritoneal dialysis
Bias in clinical research
Volume 54, Issue 2, Pages (August 1998)
Linear and logistic regression analysis
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
Acid-base profile in patients on PD
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Volume 66, Issue 4, Pages (October 2004)
Volume 59, Issue 1, Pages (January 2001)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 53, Issue 4, Pages (April 1998)
The risk of hospitalization and modality failure with home dialysis
Glucose sparing in peritoneal dialysis: Implications and metrics
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Volume 57, Issue 6, Pages (June 2000)
Volume 54, Issue 2, Pages (August 1998)
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real?  S. Andrulli, S. Di Filippo, F. Locatelli 
M. Kraemer, C. Rode, V. Wizemann  Kidney International 
Volume 59, Issue 5, Pages (May 2001)
Volume 73, Issue 4, Pages (February 2008)
Volume 78, Issue 6, Pages (September 2010)
George A. Kaysen, Burl R. Don
V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli 
Comorbidity and confounding in end-stage renal disease
A new era in phosphate binder therapy: What are the options?
Measuring transport of water across the peritoneal membrane
What really happens to people on long-term peritoneal dialysis?
Stephen P. McDonald  Kidney International Supplements 
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Charles R. Nolan, Wajeh Y. Qunibi  Kidney International 
Sunita Dheenan, William L. Henrich  Kidney International 
Volume 73, Pages S94-S101 (April 2008)
The calcium–phosphorus in guidelines for CKD-MBD
Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1  Lyndsay S. Baines, John T. Joseph,
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Volume 66, Issue 3, Pages (September 2004)
Blood pressure targets in hemodialysis patients
Volume 68, Issue 6, Pages (December 2005)
Volume 76, Issue 6, Pages (September 2009)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function  S.L.S. Fan, T. Pile, S. Punzalan, M.J.
Future of icodextrin as an osmotic agent in peritoneal dialysis
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 60, Issue 2, Pages (August 2001)
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Volume 55, Issue 5, Pages (May 1999)
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Volume 70, Pages S84-S90 (November 2006)
Volume 63, Issue 2, Pages (February 2003)
Volume 53, Issue 5, Pages (May 1998)
Quantification of free water transport in peritoneal dialysis
Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson 
Volume 67, Issue 4, Pages (April 2005)
Volume 58, Issue 2, Pages (August 2000)
Volume 65, Issue 1, Pages (January 2004)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 67, Issue 6, Pages (June 2005)
Volume 58, Issue 4, Pages (October 2000)
Volume 57, Issue 4, Pages (April 2000)
Rajni Singhal, Janet E. Hux, Shabbir M H Alibhai, Matthew J. Oliver 
Letter from W. Lornoy; I. Becaus; J.M. Billiouw and L. Sierens
Presentation transcript:

Volume 66, Issue 6, Pages 2437-2445 (December 2004) Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients  Simon J. Davies  Kidney International  Volume 66, Issue 6, Pages 2437-2445 (December 2004) DOI: 10.1111/j.1523-1755.2004.66021.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 The upper panel shows the linear best-line fit for the relationship between solute transport and UF capacity at each time-point during the study. The gradients (±95% CI), shown in the lower panel are remarkably similar, but tend to become steeper at 6 and 7 years. Kidney International 2004 66, 2437-2445DOI: (10.1111/j.1523-1755.2004.66021.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Longitudinal changes in solute transport (A) and UF capacity (B) for the whole cohort. A significant increase in solute transport was seen by 6 months and for each subsequent time point, P = 0.008 to < 0.001. A reduction in UF capacity occurred at 24 months and beyond, P = 0.047 to <0.001. For numbers of patients at each time point, see legend to Figure 1. Kidney International 2004 66, 2437-2445DOI: (10.1111/j.1523-1755.2004.66021.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 The actual mean values (SE bars) for solute transport and UF capacity at each time point (baseline, 6 months, and then yearly over 7 years, indicated as months) are shown superimposed upon the mean linear regression line (see Figure 1 for individual lines and numbers of patients at each time point). There is relative preservation of UF capacity early during treatment that later reduces disproportionately. Kidney International 2004 66, 2437-2445DOI: (10.1111/j.1523-1755.2004.66021.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Longitudinal changes in solute transport (A) and UF capacity (B) for the patients who subsequently developed UF failure (□) and the remainder of the cohort (▪). Despite better membrane function at the start of treatment, the rate of increase in solute transport tends to be faster with significantly worse UF capacity at 24 and 48 months, P < 0.05. Kidney International 2004 66, 2437-2445DOI: (10.1111/j.1523-1755.2004.66021.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 In this case two lines are plotted, that for patients with low (□) and high (♦) intraperitoneal glucose exposure during the first 12 months of dialysis treatment. At each time point, the latter group has higher solute transport and less UF capacity, but in those exposed to low glucose concentrations, membrane function is stable for the first 4 years of therapy, and UF capacity never becomes disproportionately low. See Figure 3 for description of this graph format. Kidney International 2004 66, 2437-2445DOI: (10.1111/j.1523-1755.2004.66021.x) Copyright © 2004 International Society of Nephrology Terms and Conditions